Welcome to LookChem.com Sign In|Join Free
  • or
4-Pyrimidinol, 6-cyclopropyl(7CI,8CI) is a pyrimidine derivative with the molecular formula C7H8N2O, featuring a cyclopropyl group attached to the sixth position of the pyrimidinol ring. This chemical compound is known for its unique properties and potential applications in drug development and medicinal chemistry, making it a valuable and versatile compound in the fields of chemistry and pharmaceuticals.

7038-75-7

Post Buying Request

7038-75-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7038-75-7 Usage

Uses

Used in Chemical Research:
4-Pyrimidinol, 6-cyclopropyl(7CI,8CI) is used as a building block for the synthesis of various organic molecules, contributing to the advancement of chemical research.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-Pyrimidinol, 6-cyclopropyl(7CI,8CI) serves as a key component in the development of new drugs, thanks to its unique cyclopropyl group and potential medicinal properties.

Check Digit Verification of cas no

The CAS Registry Mumber 7038-75-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,0,3 and 8 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 7038-75:
(6*7)+(5*0)+(4*3)+(3*8)+(2*7)+(1*5)=97
97 % 10 = 7
So 7038-75-7 is a valid CAS Registry Number.

7038-75-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-cyclopropyl-1H-pyrimidin-4-one

1.2 Other means of identification

Product number -
Other names 6-CYCLOPROPYL-PYRIMIDIN-4-OL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7038-75-7 SDS

7038-75-7Downstream Products

7038-75-7Relevant academic research and scientific papers

NITROGEN-CONTAINING FUSED BICYCLIC COMPOUNDS AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS

-

Paragraph 515, (2021/12/28)

The present disclosure provides compounds having Formula (I): (I) and the pharmaceutically acceptable salts and solvates thereof, wherein X1, X2, X3, X4, X5, X6, X7, X8, R1, R2, R6, R6', R7, and R7' are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to inhibit a USP1 protein and/or to treat a disorder responsive to the inhibition of USP1 proteins and USP1 activity. Compounds of the present disclosure are especially useful for treating cancer.

COMPOUNDS AS MODULATORS OF ROR GAMMA

-

Page/Page column 113, (2019/03/28)

The present invention encompasses compounds of the formula (I)(I) wherein the variables are defined herein which are suitable for the modulation of RORγ and the treatment of diseases related to the modulation of RORγ. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.

AZAINDOLE COMPOUNDS AS MODULATORS OF RORC

-

Page/Page column 68, (2015/02/25)

The present invention encompasses compounds of the formula (I), wherein the variables are defined herein which are suitable for the modulation of RORC and the treatment of diseases related to the modulation of RORC. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.

COMPOUNDS AS MODULATORS OF ROR GAMMA

-

Page/Page column 121-122, (2015/11/09)

The present invention encompasses compounds of the formula (I) wherein the variables are defined herein which are suitable for the modulation of RORγ and the treatment of diseases related to the modulation of RORγ. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7038-75-7